Cargando…

Prognostic and Predictive Molecular Markers in Cholangiocarcinoma

SIMPLE SUMMARY: Cholangiocarcinoma (CCA) is a heterogenous and aggressive malignancy of the intra- and extrahepatic biliary tract, marked by a steeply rising incidence on a global scale. While surgery remains the only curative treatment option, most patients present with advanced or unresectable dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavicevic, Sandra, Reichelt, Sophie, Uluk, Deniz, Lurje, Isabella, Engelmann, Cornelius, Modest, Dominik P., Pelzer, Uwe, Krenzien, Felix, Raschzok, Nathanael, Benzing, Christian, Sauer, Igor M., Stintzing, Sebastian, Tacke, Frank, Schöning, Wenzel, Schmelzle, Moritz, Pratschke, Johann, Lurje, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870611/ https://www.ncbi.nlm.nih.gov/pubmed/35205774 http://dx.doi.org/10.3390/cancers14041026

Ejemplares similares

Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2023)

Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
por: Krenzien, Felix, et al.
Publicado: (2022)

Simplifying minimally invasive right hepatectomy
por: Nevermann, Nora, et al.
Publicado: (2023)

Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical Implications
por: Czigany, Zoltan, et al.
Publicado: (2020)

A surgical strategy for intrahepatic cholangiocarcinoma — the hilar first concept
por: Nevermann, Nora, et al.
Publicado: (2023)

FIRE-9 – PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer
por: Raschzok, Nathanael, et al.
Publicado: (2022)

The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2022)

Transplantation programs facing lack of empirical evidence on SARS‐CoV‐2 vaccination: A society recommendation consensus update
por: Nevermann, Nora, et al.
Publicado: (2021)

Sensing Acute Cellular Rejection in Liver Transplant Patients Using Liver-Derived Extracellular Particles: A Prospective, Observational Study
por: Kamali, Kaan, et al.
Publicado: (2021)

A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2022)

A tailored approach in lymph node-positive perihilar cholangiocarcinoma
por: Benzing, Christian, et al.
Publicado: (2021)

Complexity-Adjusted Learning Curves for Robotic and Laparoscopic Liver Resection: A Word of Caution
por: Krenzien, Felix, et al.
Publicado: (2022)

Laparoscopic liver resection: indications, limitations, and economic aspects
por: Schmelzle, Moritz, et al.
Publicado: (2020)

Textbook outcome after major hepatectomy for perihilar cholangiocarcinoma — definitions and influencing factors
por: Benzing, Christian, et al.
Publicado: (2022)

Outcomes of Liver Resections after Liver Transplantation at a High-Volume Hepatobiliary Center
por: Pohl, Julian M. O., et al.
Publicado: (2020)

Over 30 Years of Pediatric Liver Transplantation at the Charité—Universitätsmedizin Berlin
por: Moosburner, Simon, et al.
Publicado: (2022)

Robotic versus laparoscopic versus open major hepatectomy – an analysis of costs and postoperative outcomes in a single-center setting
por: Knitter, Sebastian, et al.
Publicado: (2023)

Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients
por: Timmermann, Lea, et al.
Publicado: (2021)

Incidence, Diagnosis and Repair of a Diaphragmatic Hernia Following Hepatic Surgery: A Single Center Analysis of 3107 Consecutive Liver Resections
por: Raakow, Jonas, et al.
Publicado: (2021)

Validation of risk scores for allograft failure after liver transplantation in Germany: a retrospective cohort analysis
por: Moosburner, Simon, et al.
Publicado: (2023)

Validation of the Enhanced Recovery after Surgery (ERAS) society recommendations for liver surgery: a prospective, observational study
por: Schmelzle, Moritz, et al.
Publicado: (2022)

Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosis
por: Ortiz Galindo, Santiago A., et al.
Publicado: (2021)

Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size
por: Kolck, Johannes, et al.
Publicado: (2023)

The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2022)

Robotic vs. laparoscopic liver surgery: a single-center analysis of 600 consecutive patients in 6 years
por: Schmelzle, Moritz, et al.
Publicado: (2022)

Orthotopic Liver Transplantation for Budd-Chiari Syndrome: Observations from a 30-Year Liver Transplant Program
por: Ibach, Marius, et al.
Publicado: (2021)

How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients
por: Eurich, Dennis, et al.
Publicado: (2023)

Single incision laparoscopic liver resection (SILL) – a systematic review
por: Benzing, Christian, et al.
Publicado: (2015)

Prognostic significance of macrophage invasion in hilar cholangiocarcinoma
por: Atanasov, Georgi, et al.
Publicado: (2015)

The Effects of MELD-Based Liver Allocation on Patient Survival and Waiting List Mortality in a Country with a Low Donation Rate
por: Ritschl, Paul V., et al.
Publicado: (2020)

Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2023)

Predicting the Risk of Postoperative Complications in Patients Undergoing Minimally Invasive Resection of Primary Liver Tumors
por: Haber, Philipp K., et al.
Publicado: (2021)

Long-Term Outcome after Liver Transplantation for Progressive Familial Intrahepatic Cholestasis
por: Gül-Klein, Safak, et al.
Publicado: (2021)

Hilar en bloc resection for hilar cholangiocarcinoma in patients with limited liver capacities—preserving parts of liver segment 4
por: Jonas, Sven, et al.
Publicado: (2018)

Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer
por: Lurje, Isabella, et al.
Publicado: (2020)

Correction to: Hilar en bloc resection for hilar cholangiocarcinoma in patients with limited liver capacities—preserving parts of liver segment 4
por: Jonas, Sven, et al.
Publicado: (2018)

The influence of the COVID-19 pandemic on surgical therapy and care: a cross-sectional study
por: Hillebrandt, Karl H., et al.
Publicado: (2022)

Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis
por: Thevathasan, Tharusan, et al.
Publicado: (2021)

Increased Cell-Free DNA Plasma Concentration Following Liver Transplantation Is Linked to Portal Hepatitis and Inferior Survival
por: Krenzien, Felix, et al.
Publicado: (2020)

Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)
por: Schmelzle, Moritz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a1uq97lc5m7pt0eu60nbjhknrb